AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2019
Jan 8, 2019
33298_dirs_2019-01-08_703f1ca1-da93-4a67-8e74-43924af0b2d6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONVERSION LABS, INC. (CVLB)
CIK: 0000948320
Period of Report: 2019-01-04
Reporting Person: Schreiber Justin (Director, Chief Executive Officer, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-01-04 | Common Stock, par value $0.01 | P | 4900 | $0.1787 | Acquired | 3149900 | Indirect |
| 2019-01-04 | Common Stock, par value $0.01 | P | 5100 | $0.1776 | Acquired | 3155000 | Indirect |
| 2019-01-04 | Common Stock, par value $0.01 | P | 5695 | $0.15 | Acquired | 3160965 | Indirect |
| 2019-01-07 | Common Stock, par value $0.01 | J | 2375000 | — | Disposed | 0 | Indirect |
| 2019-01-07 | Common Stock, par value $0.01 | J | 2375000 | — | Acquired | 5805695 | Indirect |
Footnotes
F1: These shares were purchased on the open market.
F2: The Reporting Person transferred 2,375,000 shares of the Company's common stock that he beneficially owned, via his ownership and control of JLS Ventures, LLC to JOJ Holding, LLC, a separate entity the Reporting Person is the control person of.
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17